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Introduction to the Genomics special edition on clinical and translational genomicsThis journal was conceived and created when genomics was a young
science, described in Volume 1, issue 1 as, “a new discipline [with] a new
name.” For more than 25 years Genomics has reported on the develop-
ment and application of cutting-edge methods in genomic technology
and has published manuscripts addressing fundamental questions in
genome biology. The goal has been to present high-quality work to a
broad audience that is eager to consume the dynamically-evolving
knowledge base characteristic of this ﬁeld. This mission has mandated
that we present content not only limited to fundamental genomics, but
also spanning a variety of genomic subspecialties, including epigenomics,
evolutionary and comparative genomics, genomic technology, computa-
tional biology, genomic-scale genetics, genomics regulatory analysis,
and disease-related genomics. The result has been a track record for pub-
lishing valuable additions to the genomic literature and the development
of a loyal readership base that values this content.
As genomics continues to mature, we are now entering a period
where novel developments continue but, in addition, validated
methods are being used in both preclinical and clinical settings to inves-
tigate, diagnose, and treat human disease. These are the early days of
the era that we envisioned some 25 years ago: the fruition of the latter
half of the often-cited “bench to bedside”model for translational geno-
mics research. As part of the journal's ongoing effort to remain on the
cutting edge of genomics, the time seemed appropriate to reiterate
and emphasize our commitment to publishing reports of high-quality
preclinical and clinical translational genomics investigations. For this
reason we have designated this issue as a “special edition on clinical
and translational genomics” and have taken the opportunity to show-
case some of the types of applied genomics investigations that we
believe represent a critical part of the future scope of Genomics.0888-7543/$ – see front matter © 2013 Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.ygeno.2013.07.004As this edition's selection of articles illustrates, the topic of “clinical
and translational genomics” encompasses a broad spectrum of subjects.
Speciﬁc topics of interest to Genomics include such diverse issues as
associations between genomic signatures and therapeutic response,
genomic markers of clinical risk and prognosis, molecular subgroups
of diseases that have clinically-relevant phenotypic differences, mathe-
matical and computational models for analyzing genomic data in a
clinical context, or any of a number of others. While they may appear
superﬁcially dissimilar, these topics are all fundamentally uniﬁed in
their focus on using novel genomic innovations and technologies to
address practical challenges in clinical patientmanagement.We believe
that this category of research represents an important part of the future
of genomics—both the journal and the discipline on which it reports.
While we continue to welcome basic science investigations related
to any and all constituents of the broad discipline of genomics, we
also invite applied researchers, translational investigators, and clini-
cians with expertise in genomics to submit manuscripts detailing
current and future applications of genome technologies to clinical
decision-making and to patient care. We look forward to incorporating
such reports into the comprehensive repertoire of research on which
Genomics reports, and we believe that the efforts to these ends will
help keep this journal focused on the leading edge ofmodern genomics.
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